M. Perenna Rogers

692 total citations
29 papers, 607 citations indexed

About

M. Perenna Rogers is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Perenna Rogers has authored 29 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Perenna Rogers's work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipid metabolism and disorders (10 papers) and Adipose Tissue and Metabolism (6 papers). M. Perenna Rogers is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipid metabolism and disorders (10 papers) and Adipose Tissue and Metabolism (6 papers). M. Perenna Rogers collaborates with scholars based in United Kingdom, United States and Ireland. M. Perenna Rogers's co-authors include Donald S. Robinson, Jason D. Oliver, Timothy J. Panella, David C. Smith, S. Clifford Schold, Robert L. Fine, Eric P. Winer, D L Trump, Peter C. Whybrow and V. Craig Jordan and has published in prestigious journals such as American Journal of Psychiatry, JNCI Journal of the National Cancer Institute and Biochemical Journal.

In The Last Decade

M. Perenna Rogers

29 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Perenna Rogers United Kingdom 14 311 150 125 110 90 29 607
M. De Luise Australia 14 314 1.0× 189 1.3× 218 1.7× 146 1.3× 192 2.1× 23 895
Birgit Heller Germany 6 298 1.0× 321 2.1× 92 0.7× 77 0.7× 132 1.5× 9 750
Z Rymaszewski United States 12 212 0.7× 54 0.4× 173 1.4× 60 0.5× 87 1.0× 28 642
Lee A. Bricker United States 14 244 0.8× 83 0.6× 86 0.7× 44 0.4× 75 0.8× 28 560
D. Denis Belgium 17 275 0.9× 179 1.2× 77 0.6× 23 0.2× 183 2.0× 36 818
Marisa Viñals Spain 10 332 1.1× 115 0.8× 175 1.4× 96 0.9× 161 1.8× 13 873
Oleg G. Khatsenko United States 10 535 1.7× 87 0.6× 93 0.7× 53 0.5× 196 2.2× 14 1.0k
Tadasu Ikeda Japan 11 211 0.7× 100 0.7× 196 1.6× 40 0.4× 95 1.1× 31 472
Jun Gu China 18 351 1.1× 140 0.9× 46 0.4× 49 0.4× 56 0.6× 30 848
Shefalee K. Bhavsar Germany 19 513 1.6× 78 0.5× 102 0.8× 89 0.8× 283 3.1× 32 883

Countries citing papers authored by M. Perenna Rogers

Since Specialization
Citations

This map shows the geographic impact of M. Perenna Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Perenna Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Perenna Rogers more than expected).

Fields of papers citing papers by M. Perenna Rogers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Perenna Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Perenna Rogers. The network helps show where M. Perenna Rogers may publish in the future.

Co-authorship network of co-authors of M. Perenna Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of M. Perenna Rogers. A scholar is included among the top collaborators of M. Perenna Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Perenna Rogers. M. Perenna Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rogers, M. Perenna, Richard B. Lock, Daniel M. Sullivan, et al.. (1999). Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIα and β. Cancer Chemotherapy and Pharmacology. 44(4). 275–282. 13 indexed citations
2.
Oliver, Jason D. & M. Perenna Rogers. (1993). Effects of retinoic acid on lipoprotein lipase activity and mRNA level in vitro and in vivo. Biochemical Pharmacology. 45(3). 579–583. 10 indexed citations
3.
Oliver, Jason D. & M. Perenna Rogers. (1993). Stimulation of lipoprotein lipase synthesis by refeeding, insulin and dexamethasone. Biochemical Journal. 292(2). 525–530. 24 indexed citations
4.
Rogers, M. Perenna, et al.. (1992). Lipoprotein lipase in heart and myocytes: Characteristics with intralipid as substrate. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 101(3). 327–331. 1 indexed citations
5.
Trump, D L, David C. Smith, Peter Ellis, et al.. (1992). High-Dose Oral Tamoxifen, a Potential Multidrug-Resistance-Reversal Agent: Phase I Trial in Combination With Vinblastine. JNCI Journal of the National Cancer Institute. 84(23). 1811–1816. 186 indexed citations
6.
Panella, Timothy J., David C. Smith, S. Clifford Schold, et al.. (1992). Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.. PubMed. 52(9). 2456–9. 24 indexed citations
7.
Rogers, M. Perenna, et al.. (1991). Phosphorylation and activation of hormone‐sensitive lipase in isolated macrophages. FEBS Letters. 279(2). 323–326. 40 indexed citations
8.
Cochrane, W. A. & M. Perenna Rogers. (1990). Sensitivity of freshly isolated ovine adipocytes to inhibition of lipolysis by insulin. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 96(2). 331–333. 1 indexed citations
9.
Rogers, M. Perenna, et al.. (1989). Effects of isotretinoin on lipid metabolism in the rat. Archives of Dermatological Research. 281(2). 116–118. 4 indexed citations
10.
Rogers, M. Perenna. (1989). Plasma lipoproteins‐new comprehensive biochemistry, vol. 14. FEBS Letters. 256(1-2). 236–236. 2 indexed citations
11.
Mackay, Alan & M. Perenna Rogers. (1989). Lipoprotein lipase mRNA in rat tissues. Biochemical Society Transactions. 17(1). 177–177. 2 indexed citations
13.
Rogers, M. Perenna. (1987). Biochemistry and biology of plasma lipoproteins. FEBS Letters. 224(1). 236–237. 16 indexed citations
14.
Rogers, M. Perenna, et al.. (1985). Reconstituted high density lipoprotein behaviour is modified by the nature of the lipid vesicle. FEBS Letters. 180(1). 66–68. 1 indexed citations
15.
Turnbull, Douglass M., et al.. (1984). Metabolic changes in fed rats caused by chronic administration of ethyl 2{5(4-chlorophenyl) pentyl}oxirane-2-carboxylate, a new hypoglycaemic compound. Biochemical Pharmacology. 33(3). 465–473. 25 indexed citations
16.
Rogers, M. Perenna, et al.. (1984). Effects of ethyl-CPIB (clofibrate) on tissue lipoprotein lipase and plasma post-heparin lipolytic activity in rats. Biochemical Pharmacology. 33(8). 1337–1341. 8 indexed citations
17.
Rogers, M. Perenna & I Hutchinson. (1981). The effect in vitro of high-density lipoprotein on hydrolysis of triacylglycerol by lipoprotein lipase. Biochemical Journal. 200(2). 453–456. 13 indexed citations
18.
Rogers, M. Perenna, David A. Barnett, & Donald S. Robinson. (1976). Clearing factor lipase (lipoprotein lipase) activator A method for the measurement of the net activating ability of human sera. Atherosclerosis. 24(3). 551–564. 13 indexed citations
20.
Rogers, M. Perenna & Donald S. Robinson. (1974). Effects of cold exposure on heart clearing factor lipase and triglyceride utilization in the rat. Journal of Lipid Research. 15(3). 263–272. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026